𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Cardiomyopathy in Friedreich's ataxia-assessment by cardiac MRI

✍ Scribed by Chris Meyer; Gebhard Schmid; Sabine Görlitz; Monika Ernst; Christian Wilkens; Inga Wilhelms; Peter H. Kraus; Peter Bauer; Jürgen Tomiuk; Horst Przuntek; Andreas Mügge; Ludger Schöls


Publisher
John Wiley and Sons
Year
2007
Tongue
English
Weight
234 KB
Volume
22
Category
Article
ISSN
0885-3185

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Cardiomyopathy is an important and frequently life limiting manifestation of Friedreich's ataxia (FA), the most prevalent form of autosomal recessive ataxia. Left ventricular mass is used as primary outcome measure in recent intervention studies but systematic analyses of FA cardiomyopathy are sparse. To assess cardiac hypertrophy by cardiac magnetic resonance imaging (MRI) in vivo, we assessed 41 adult patients with genetically confirmed FA and 33 age‐ and sex‐matched healthy controls by cardiac MRI and echocardiogarphy. Septal hypertrophy and left ventricular mass index were determined by two independent raters. MRI revealed hypertrophy of the interventricular septum in 40% and increased left ventricular mass index in 29% of patients. Interobserver variability was less than 5% for both measures. GAA repeat length had only minor influence on interventricular septum thickness. Left ventricular mass index decreased with age. Severity of ataxia did not correlate with cardiac disease. In echocardiography wall diameter was assessable only in 31 of 41 FA patients with 32% of patients presenting septal hypertrophy and 6% increased left ventricular mass index. We conclude that cardiac hypertrophy is present only in a minority of adult FA patients. If despite this limitation intervention studies use left ventricular mass as outcome measure, MRI is recommended as the most accurate assessment of cardiac anatomy in vivo. © 2007 Movement Disorder Society


📜 SIMILAR VOLUMES


Cardiac bioenergetics in Friedreich's at
✍ Raffaele Lodi; Bheeshma Rajagopalan; Anthony H. V. Schapira; J. Mark Cooper 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 79 KB
Analysis of the factors influencing the
✍ Bheeshma Rajagopalan; Jane M. Francis; Fraser Cooke; L. V. Prasad Korlipara; And 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 110 KB

Friedreich's ataxia (FRDA) has been associated with both cardiac hypertrophy and to a lesser degree dilated cardiomyopathy. We have conducted a cross sectional magnetic resonance imaging (MRI) study of 25 patients with clinically and genetically confirmed FRDA and 24 healthy controls to analyse how

Co-existence of frataxin and cardiac tro
✍ Giovanni Cuda; Andrea Mussari; Daniela Concolino; Francesco S. Costanzo; Pietro 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 208 KB

Friedreich Ataxia (FA) is a neurodegenerative disorder characterised by progressive gait disturbance, dysarthria, dysmetria and other coordination disorders. The genetic defect is represented by an expansion of GAA repeats in the frataxin gene (FRDA or X25). Hypertrophic cardiomyopathy is a common f

Antioxidant treatment improves in vivo c
✍ Raffaele Lodi; Paul E. Hart; Bheeshma Rajagopalan; Doris J. Taylor; Jenifer G. C 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 168 KB 👁 2 views

## Abstract Friedreich's ataxia (FA) is the most common form of autosomal recessive spinocerebellar ataxia and is often associated with a cardiomyopathy. The disease is caused by an expanded intronic GAA repeat, which results in deficiency of a mitochondrial protein called __frataxin__. In the yeas